We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$140M |
| 2 |
Microsoft
MSFT
|
+$124M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Carrier Global
CARR
|
+$94.7M |
| 5 |
Otis Worldwide
OTIS
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$47.8M |
| 2 |
Abbott
ABT
|
+$25.1M |
| 3 |
Colgate-Palmolive
CL
|
+$24.3M |
| 4 |
Hormel Foods
HRL
|
+$23.2M |
| 5 |
Walmart Inc
WMT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.79% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Lear
LEA
$7.19B
| $411K | ﹤0.01% |
+3,768
| New | +$375K |
|
1052
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $411K | ﹤0.01% |
9,798
+2,590
| +36% | +$103K |
|
|
RVNC
1053
DELISTED
Revance Therapeutics, Inc.
RVNC
| $411K | ﹤0.01% |
16,834
+6,712
| +66% | +$132K |
|
1054
Itron
ITRI
$3.73B
| $409K | ﹤0.01% |
+6,177
| New | +$393K |
|
1055
Regenxbio
RGNX
$623M
| $409K | ﹤0.01% |
11,110
+3,570
| +47% | +$133K |
|
1056
RLJ Lodging Trust
RLJ
$1.87B
| $408K | ﹤0.01% |
43,254
+13,861
| +47% | +$130K |
|
|
ESPR
1057
DELISTED
Esperion Therapeutics
ESPR
| $407K | ﹤0.01% |
+7,932
| New | +$332K |
|
1058
Watsco Inc
WSO
$14.9B
| $407K | ﹤0.01% |
2,289
+976
| +74% | +$162K |
|
1059
Thor Industries
THO
$3.99B
| $405K | ﹤0.01% |
+3,800
| New | +$297K |
|
1060
Commault Systems
CVLT
$5.89B
| $404K | ﹤0.01% |
10,444
+4,883
| +88% | +$194K |
|
1061
SPS Commerce
SPSC
$2.25B
| $403K | ﹤0.01% |
+5,360
| New | +$327K |
|
1062
Karyopharm Therapeutics
KPTI
$168M
| $402K | ﹤0.01% |
1,415
+607
| +75% | +$180K |
|
1063
MacroGenics
MGNX
$235M
| $401K | ﹤0.01% |
+14,351
| New | +$249K |
|
|
PE
1064
DELISTED
PARSLEY ENERGY INC
PE
| $401K | ﹤0.01% |
37,544
+16,459
| +78% | +$152K |
|
1065
Flowserve
FLS
$9.25B
| $399K | ﹤0.01% |
13,980
+2,311
| +20% | +$61.7K |
|
|
AMRN
1066
Amarin Corp
AMRN
$284M
| $396K | ﹤0.01% |
2,859
+417
| +17% | +$57.4K |
|
|
CXP
1067
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $395K | ﹤0.01% |
30,058
+16,672
| +125% | +$220K |
|
1068
Dell
DELL
$283B
| $394K | ﹤0.01% |
14,164
+2,537
| +22% | +$57K |
|
1069
Advanced Energy
AEIS
$12.2B
| $393K | ﹤0.01% |
+5,804
| New | +$346K |
|
1070
Rithm Capital
RITM
$5.09B
| $391K | ﹤0.01% |
52,655
+5,059
| +11% | +$32.7K |
|
1071
Tapestry
TPR
$28.8B
| $390K | ﹤0.01% |
29,403
+5,015
| +21% | +$71.2K |
|
|
ISBC
1072
DELISTED
Investors Bancorp, Inc.
ISBC
| $390K | ﹤0.01% |
45,835
+19,831
| +76% | +$167K |
|
1073
Credit Acceptance
CACC
$6B
| $389K | ﹤0.01% |
929
+50
| +6% | +$17.4K |
|
1074
Bankunited
BKU
$3.38B
| $386K | ﹤0.01% |
+19,082
| New | +$358K |
|
1075
LivePerson
LPSN
$18.9M
| $386K | ﹤0.01% |
+621
| New | +$289K |
|
Similar funds
ProShare Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, ProShare Advisors held 1,702 positions worth $18.7B, up 35% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $1.69B of net new capital in Q2 2020, opening 548 new positions and adding to 855 existing holdings. Its largest new stake was Carrier Global: 5,097,223 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $47.8M trimmed.
- ProShare Advisors's largest Q2 2020 buy was Carrier Global: 5,097,223 shares worth $113M.
- ProShare Advisors added most to Amazon in Q2 2020, an estimated $140M increase.
- ProShare Advisors's biggest Q2 2020 reduction was Clorox, cutting an estimated $47.8M.
- ProShare Advisors fully exited Utah Medical Products in Q2 2020, selling an estimated $11.6M.
- ProShare Advisors's ten largest holdings make up 24% of its $18.7B portfolio in Q2 2020.
- ProShare Advisors opened 548 new positions and closed 34 in Q2 2020.
- ProShare Advisors's portfolio value rose 35% quarter-over-quarter to $18.7B.
Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.